WallStreetZenWallStreetZen

NASDAQ: INGN
Inogen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INGN

Based on 1 analyst offering 12 month price targets for Inogen Inc

Min Forecast
$12.00+107.97%
Avg Forecast
$12.00+107.97%
Max Forecast
$12.00+107.97%

Should I buy or sell INGN stock?

Based on 1 analyst offering ratings for Inogen Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although INGN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates INGN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their INGN stock forecasts and price targets.

INGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-07

1 of 1

Forecast return on equity

Is INGN forecast to generate an efficient return?

Company
N/A
Industry
22.21%
Market
167.34%

Forecast return on assets

Is INGN forecast to generate an efficient return on assets?

Company
N/A
Industry
13.78%

INGN earnings per share forecast

What is INGN's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.78
Avg 2 year Forecast
-$0.48
Avg 3 year Forecast
-$0.28

INGN revenue forecast

What is INGN's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$363.5M+2.6%
Avg 2 year Forecast
$380.1M+7.27%
Avg 3 year Forecast
$402.5M+13.61%
INGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INGN revenue growth forecast

How is INGN forecast to perform vs Medical Devices companies and vs the US market?

Company
4.26%
Industry
7.26%
Market
14.52%
INGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INGN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
INGN$5.77$12.00+107.97%Strong Buy
QTRX$3.44$3.00-12.79%Hold
LUCD$0.60$4.67+677.83%Strong Buy
RXST$4.65$7.43+59.68%Hold
MXCT$1.09N/AN/A
View Top Medical Device Stocks

Inogen Stock Forecast FAQ

Is Inogen Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: INGN) stock is to Strong Buy INGN stock.

Out of 1 analyst, 1 (100%) are recommending INGN as a Strong Buy, 0 (0%) are recommending INGN as a Buy, 0 (0%) are recommending INGN as a Hold, 0 (0%) are recommending INGN as a Sell, and 0 (0%) are recommending INGN as a Strong Sell.

If you're new to stock investing, here's how to buy Inogen stock.

What is INGN's earnings growth forecast for 2026-2028?

(NASDAQ: INGN) Inogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.52%.

Inogen's earnings in 2026 is -$24,595,000.On average, 4 Wall Street analysts forecast INGN's earnings for 2026 to be -$20,707,864, with the lowest INGN earnings forecast at -$21,066,132, and the highest INGN earnings forecast at -$20,062,983. On average, 4 Wall Street analysts forecast INGN's earnings for 2027 to be -$12,857,824, with the lowest INGN earnings forecast at -$15,604,542, and the highest INGN earnings forecast at -$9,752,839.

In 2028, INGN is forecast to generate -$7,308,658 in earnings, with the lowest earnings forecast at -$10,663,104 and the highest earnings forecast at -$3,622,483.

What is INGN's revenue growth forecast for 2026-2028?

(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 4.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.52%.

Inogen's revenue in 2026 is $354,304,000.On average, 4 Wall Street analysts forecast INGN's revenue for 2026 to be $9,647,481,650, with the lowest INGN revenue forecast at $9,235,341,276, and the highest INGN revenue forecast at $9,967,533,994. On average, 4 Wall Street analysts forecast INGN's revenue for 2027 to be $10,085,894,977, with the lowest INGN revenue forecast at $9,573,439,689, and the highest INGN revenue forecast at $10,508,119,919.

In 2028, INGN is forecast to generate $10,682,742,176 in revenue, with the lowest revenue forecast at $10,033,614,453 and the highest revenue forecast at $11,243,762,620.

What is INGN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: INGN) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.78%.

What is INGN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year INGN price target, the average INGN price target is $12.00, with the highest INGN stock price forecast at $12.00 and the lowest INGN stock price forecast at $12.00.

The Wall Street analyst predicted that Inogen's share price could reach $12.00 by Apr 7, 2027. The average Inogen stock price prediction forecasts a potential upside of 107.97% from the current INGN share price of $5.77.

What is INGN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: INGN) Inogen's current Earnings Per Share (EPS) is -$0.91. On average, analysts forecast that INGN's EPS will be -$0.78 for 2026, with the lowest EPS forecast at -$0.79, and the highest EPS forecast at -$0.76. On average, analysts forecast that INGN's EPS will be -$0.48 for 2027, with the lowest EPS forecast at -$0.59, and the highest EPS forecast at -$0.37. In 2028, INGN's EPS is forecast to hit -$0.28 (min: -$0.40, max: -$0.14).

What is INGN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: INGN) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.